Efficacy of aluminium foil reflector-enhanced phototherapy in term neonates with hyperbilirubinemia: A randomized controlled trial

< 0.0001). The treatment effect remained significant after adjustment for gestational age and postnatal age using ANCOVA. No significant differences in adverse events were observed.ConclusionsAluminium foil reflector-assisted phototherapy was associated with faster bilirubin reduction and shorter treatment duration without increased adverse effects. This low-cost modification may improve phototherapy efficiency in resource-limited neonatal care settings.